Vitamin D deficiency: The surprising supplement that could stave off the condition
VITAMIN D helps regulate the amount of calcium and phosphate in the body, which are needed to keep bones, teeth and muscles healthy. (Source: Daily Express - Health)
Source: Daily Express - Health - October 10, 2021 Category: Consumer Health News Source Type: news

Common blood pressure pills taken by millions of Brits may raise the risk of psoriasis, study warns
A review of 21 studies by Korean researchers found common drugs ACE inhibitors, beta blockers, calcium channel blockers (CCBs) and thiazide diuretics, increased the risk of psoriasis. (Source: the Mail online | Health)
Source: the Mail online | Health - October 6, 2021 Category: Consumer Health News Source Type: news

Peninsula biotech looks to turn once-failed osteoporosis drug against rare disease
A Bay Area company went on the hunt for a certain class of drugs that could level off calcium levels in both the blood and urine. Now it plans to take a drug into a late-stage clinical trial for people at risk of deadly kidney disease. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 1, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

Peninsula biotech looks to turn once-failed osteoporosis drug against rare disease
A Bay Area company went on the hunt for a certain class of drugs that could level off calcium levels in both the blood and urine. Now it plans to take a drug into a late-stage clinical trial for people at risk of deadly kidney disease. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 1, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Peninsula biotech looks to turn once-failed osteoporosis drug against rare disease
A Bay Area company went on the hunt for a certain class of drugs that could level off calcium levels in both the blood and urine. Now it plans to take a drug into a late-stage clinical trial for people at risk of deadly kidney disease. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 1, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

Peninsula biotech looks to turn once-failed osteoporosis drug against rare disease
A Bay Area company went on the hunt for a certain class of drugs that could level off calcium levels in both the blood and urine. Now it plans to take a drug into a late-stage clinical trial for people at risk of deadly kidney disease. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 1, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Silent Coronary Atherosclerosis Prevalent on CT in Middle Age Silent Coronary Atherosclerosis Prevalent on CT in Middle Age
CT angiography also detected atherosclerosis in cases missed by coronary artery calcium testing in a population-based cohort without known heart disease.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 28, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

From Imaging to Kinetics: Measuring Calcium Signaling
Streamlining and automating cell-based assays for measuring intracellular calcium. (Source: The Scientist)
Source: The Scientist - September 27, 2021 Category: Science Tags: The Marketplace Source Type: news

What Looks Like Acrocyanosis?
Discussion Acrocyanosis is a peripheral vascular disease where the skin and mucous membranes have a persistent, painless, deep-bluish color due to decreased oxygenated blood which usually is benign. The deoxygenated blood can be due to a central cause such as cyanotic congenital heart disease or localized problems often due to vasospasm. Hands and feet are the most common areas affected. It is thought that there is “…vasospasm of the cutaneous arteries, and arterioles along with compensatory dilatation in the capillary and post capillary venules caus[ing] cyanosis and sweating.” Palms and soles may or may...
Source: PediatricEducation.org - September 27, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Physical Activity Paradoxically Tied to Higher Coronary Calcium Physical Activity Paradoxically Tied to Higher Coronary Calcium
In this population-based study, more physical activity was associated with a faster progression of the coronary artery calcium score, indicating a greater build-up of plaque in the coronary arteries.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 23, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Rosuvastatin Calcium (marketed as Crestor) Information
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 21, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Study: Exercise benefits heart, but could increase calcium deposits in arteries
Physical activity, though generally beneficial for the heart, may in some cases increase a person's risk for heart disease, a study published Monday by the journal Heart found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 20, 2021 Category: Consumer Health News Source Type: news

Janssen Presents Results from Phase 1b/2 NORSE Study in Patients with Metastatic or Locally Advanced Urothelial Carcinoma Treated with BALVERSA ® (erdafitinib) in Combination with Cetrelimab, a PD-1 Inhibitor
September 17, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 1b/2 NORSE (NCT03473743) study evaluating BALVERSA® (erdafitinib) in combination with cetrelimab, an anti-programmed cell death protein 1 (PD-1) monoclonal antibody, compared to BALVERSA® monotherapy in patients with locally advanced or metastatic urothelial carcinoma (mUC) with fibroblast growth factor receptor (FGFR)3 or FGFR2 genetic alterations who are ineligible for cisplatin, a current standard of care treatment for mUC. The results were highlighted in an oral presentation at t...
Source: Johnson and Johnson - September 17, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Cardiac PET predicts outcomes in aortic stenosis
PET imaging has shown how impaired blood flow in small vessels of the hear...Read more on AuntMinnie.comRelated Reading: Deep-learning algorithm can detect, quantify aortic valve calcium PET ties coronary blood flow to future adverse events Nuclear medicine groups oppose Humana PET/CT policy 3D printing enhances planning of TAVR procedures CT helps predict TAVR outcomes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 16, 2021 Category: Radiology Source Type: news

Prognosis of vital pulp therapy on permanent dentition: a systematic review and meta-analysis of randomized controlled trials
ConclusionsWhen MTA or CSM was used as a capping material, VPT was 93% successful. The techniques, etiologies, developmental stages of teeth, or preoperative diagnosis had no significant influence on treatment outcomes. No major adverse effects (except discoloration associated with the use of MTA) were identified. The overall quality of evidence was low. (Source: Dental Technology Blog)
Source: Dental Technology Blog - September 14, 2021 Category: Dentistry Source Type: news